LexaGene to Present at the SNN Network Summer Virtual Event

by | Aug 16, 2021 | Investor Information

Home » Investor Information » LexaGene to Present at the SNN Network Summer Virtual Event

Dr. Jack Regan, our Founder and CEO, will present at this year’s SNN Network Summer Virtual Event on Thursday, August 19th. In addition to taking live questions from investors, Dr. Regan will be available for 1-on-1 meetings during the event.

“Since launching MiQLab™, we’ve experienced a tremendous amount of growth and positive momentum resulting from a number of scientific studies that have produced robust data validating our system’s efficacy,” said Dr. Jack Regan. “As we move ahead with our commercialization strategies, we continue to see great promise in the space of veterinary diagnostics, food safety, and biopharmaceutical manufacturing. We believe, MiQLab will change the way these industries conduct their business, for the better. I’m excited to speak to investors at this year’s SNN Network Virtual Event and share our vision for the future of molecular diagnostic testing.”

To register, visit SNN’s conference registration page.

Read more on Accesswire.

<a href="https://lexagene.com/author/lexagene-admin/" target="_self">LexaGene</a>

LexaGene

LexaGene is a molecular diagnostics company that has commercialized the MiQLab System for fast and easy detection of biological contaminants, pathogens and other molecular markers.

The Value of a Filter-Based Sample Preparation Cartridge Used in a PCR Device for Sensitive and Rapid Detection of Contaminants

LexaGene’s MiQLab™ System is the only fully automated system on the market today that is equipped with a disposable filter-based sample preparation cartridge that allows for efficient processing of large volumes of sample for sensitive detection of contaminants.

Survey Says Veterinarians Have an Appetite for In-Clinic Diagnostic Technology

This spring LexaGene conducted a market research survey in conjunction with AAHA to assess the opinions of practicing veterinarians on AMR stewardship and the use of antibiotics in the treatment of companion animals.

The Dawn of the Superbugs

The most menacing of all resistant bacteria are the so called “super bugs”- strains of bacteria that are resistant to several different classes of antibiotics or multidrug resistant.

Upcoming Events

LexaGene logo

Annual General Shareholder Meeting

Virtual
February 08, 2023
LexaGene's Annual General Shareholder Meeting will be held on February 8th, 2023.
1 2 3 7

Latest Resources


Listen to CEO and Founder, Dr. Jack Regan tell the LexaGene story to prospective investors, October 7, 2021.
1 2 3 5